Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05250180 · ClinicalTrials.gov registry record · NA

Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.

A NA study of Brain Injuries, sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05250180: Recruiting NA study of Brain Injuries, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT05250180 is a NA study of Brain Injuries that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 90 participants, below the 327-participant average among 22 other Brain Injuries trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05250180, a NA study of Brain Injuries, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Children requiring inpatient rehabilitation treatment following acquired brain injury (ABI) are at risk for poor engagement in rehabilitative therapies. A within subject crossover design will be used to determine whether involving dogs in physical and occupational therapies while receiving inpatient rehabilitation improves patient engagement, how involving dogs improves engagement, and identify who is most likely to benefit. This project addresses the critical need to establish an evidence base for animal-assisted therapies in pediatric rehabilitation, incorporates innovative methods, and has the potential to lead to improved clinical care for children and adolescents receiving intensive rehabilitation following ABI.

Primary Outcome

Patient engagement/participation will be assessed via the Pittsburgh Rehabilitation Participation Scale (PRPS) is a 6-item Likert-type, clinician-rated measure that quantifies observed patient participation/engagement in their therapy sessions. Therapists will report their observations regarding patient's completion of exercises, effort applied to exercises, and level of support needed to complete activities.

Conditions Studied

Interventions

  • OTHER Control
  • OTHER Animal Assisted Therapy

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2022-07-22
Est. Completion 2026-06-30
Phase NA

What NCT05250180 shows while recruiting

NCT05250180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 327-participant average among 22 other Brain Injuries trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Brain Injuries appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT05250180 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05250180 about?

NCT05250180 is a clinical study titled "Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.". Children requiring inpatient rehabilitation treatment following acquired brain injury (ABI) are at risk for poor engagement in rehabilitative therapies. A within subject crossover design will be used to determine whether involving dogs in physical and occupational therapies while receiving inpatient...

What is the current status of trial NCT05250180?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-07-22. Estimated completion is 2026-06-30.

What conditions does trial NCT05250180 study?

This clinical trial studies the following conditions: Brain Injuries.

What interventions are being tested in trial NCT05250180?

The interventions under investigation include: Control (OTHER), Animal Assisted Therapy (OTHER).

Who is sponsoring clinical trial NCT05250180?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05250180 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05250180's enrollment target sits among peer trials

90 13th of 22 higher than 10 of 22 other Brain Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05250180, the US trial registry maintained by the National Library of Medicine. NCT05250180 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.